Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Neumora Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative therapies for brain diseases. Its pipeline includes programs targeting neuropsychiatric and neurodegenerative disorders, such as depression, dementia-related agitation, schizophrenia, ALS, and Parkinson’s disease. The company leverages novel mechanisms, AI-driven precision neuroscience, and proprietary compounds to address unmet medical needs in mental health and neurodegeneration.
This description was generated via AI from an annual report. Updated about 1 year ago.